384 related articles for article (PubMed ID: 33117795)
1. Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins.
Li J; Zhu Y
Front Cell Dev Biol; 2020; 8():548335. PubMed ID: 33117795
[TBL] [Abstract][Full Text] [Related]
2. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma.
Li N; Zhu Y
Therap Adv Gastroenterol; 2019; 12():1756284818821560. PubMed ID: 30719075
[TBL] [Abstract][Full Text] [Related]
3. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma.
Lv D; Chen L; Du L; Zhou L; Tang H
Front Cell Dev Biol; 2021; 9():691410. PubMed ID: 34368140
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
5. Research Progress on Regulating LncRNAs of Hepatocellular Carcinoma Stem Cells.
Zhang X; Zhu Y
Onco Targets Ther; 2021; 14():917-927. PubMed ID: 33603396
[TBL] [Abstract][Full Text] [Related]
6. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.
Wang N; Wang S; Li MY; Hu BG; Liu LP; Yang SL; Yang S; Gong Z; Lai PBS; Chen GG
Ther Adv Med Oncol; 2018; 10():1758835918816287. PubMed ID: 30622654
[TBL] [Abstract][Full Text] [Related]
8. Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.
Qiu L; Li H; Fu S; Chen X; Lu L
Oncol Lett; 2018 Feb; 15(2):2039-2048. PubMed ID: 29434903
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer stem cells as a therapeutic approach in liver cancer.
Zhou G; Wilson G; George J; Qiao L
Curr Gene Ther; 2015; 15(2):161-70. PubMed ID: 25537770
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.
Huo X; Han S; Wu G; Latchoumanin O; Zhou G; Hebbard L; George J; Qiao L
Mol Cancer; 2017 Oct; 16(1):165. PubMed ID: 29061150
[TBL] [Abstract][Full Text] [Related]
13. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
Shen YN; He HG; Shi Y; Cao J; Yuan JY; Wang ZC; Shi CF; Zhu N; Wei YP; Liu F; Huang JL; Yang GS; Lu JH
Mol Carcinog; 2017 Feb; 56(2):751-760. PubMed ID: 27478926
[TBL] [Abstract][Full Text] [Related]
15. Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells.
Chai S; Ng KY; Tong M; Lau EY; Lee TK; Chan KW; Yuan YF; Cheung TT; Cheung ST; Wang XQ; Wong N; Lo CM; Man K; Guan XY; Ma S
Hepatology; 2016 Dec; 64(6):2062-2076. PubMed ID: 27639189
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma.
Lin X; Xiaoqin H; Jiayu C; Li F; Yue L; Ximing X
Hepatol Res; 2019 Aug; 49(8):902-918. PubMed ID: 30945380
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy.
Chen C; Wang G
World J Hepatol; 2015 Jul; 7(15):1964-70. PubMed ID: 26244070
[TBL] [Abstract][Full Text] [Related]
18. Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α.
Zheng BN; Ding CH; Chen SJ; Zhu K; Shao J; Feng J; Xu WP; Cai LY; Zhu CP; Duan W; Ding J; Zhang X; Luo C; Xie WF
Theranostics; 2019; 9(9):2606-2617. PubMed ID: 31131056
[No Abstract] [Full Text] [Related]
19. Low-level shear stress induces differentiation of liver cancer stem cells via the Wnt/β-catenin signalling pathway.
Sun J; Luo Q; Liu L; Song G
Exp Cell Res; 2019 Feb; 375(1):90-96. PubMed ID: 30599139
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
Wong CM; Tsang FH; Ng IO
Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
